Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
SYMBICORT TURBUHALER, RILAST TURBUHALER, SYMBICORT RAPIHALER (AstraZeneca Pty Ltd)
Product name
SYMBICORT TURBUHALER, RILAST TURBUHALER, SYMBICORT RAPIHALER
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
218 working days (255)
Active ingredients
budesonide / formoterol fumarate dihydrate
Registration type
EOI
Indication
SYMBICORT TURBUHALER, RILAST TURBUHALER, SYMBICORT RAPIHALER (powder for inhalation) are now also indicated in adults and adolescents (12 years and older), for the treatment of asthma, to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see Section 4.2 Dose and method of administration).